Peptides & Peptide Synthesis Products

EDC.HCl

EDC.HCl

$20.00
$20.00
EDC.HCl, Catalog No: 31012
1-Ethyl-3-(3-dimethyllaminopropyl)carbodiimide hydrochloride, CAS: 25952-53-8, MW: 191.70, Formula: C8H18ClN3
Catalog No: 31012
1-Ethyl-3-(3-dimethyllaminopropyl)carbodiimide hydrochloride, CAS: 25952-53-8, MW: 191.70, Formula: C8H18ClN3
Description

Details

1-Ethyl-3-(3-dimethyllaminopropyl)carbodiimide hydrochloride
Additional Information

Additional Information

Catalog Number 31012
CAS 25952-53-8
M.W. 191.70
Formula C8H18ClN3
IUPAC Name 3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine;hydrochloride
Synonym 1-Ethyl-3-(3-dimethyllaminopropyl)carbodiimide hydrochloride
Also Known As
  • 3-(ethyliminomethylideneamino)propyl-dimethylazanium chloride
  • 3-(ethyliminomethyleneamino)propyl-dimethyl-ammonium chloride
  • 3-(ethyliminomethyleneamino)propyl-dimethylammonium chloride
  • 3-(ethyliminomethylideneamino)propyl-dimethyl-azanium chloride
  • NSC97064
  • 3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine hydrochloride
  • 3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine; hydron; chloride
  • 3-(ethyliminomethyleneamino)-N,N-dimethyl-propan-1-amine hydrochloride
  • 3-(ethyliminomethyleneamino)-N,N-dimethyl-propan-1-amine; hydron; chloride
  • 3-(ethyliminomethyleneamino)-N,N-dimethylpropan-1-amine hydrochloride
  • 3-(ethyliminomethyleneamino)-N,N-dimethylpropan-1-amine; hydron; chloride
  • 3-(ethyliminomethyleneamino)propyl-dimethyl-amine hydrochloride
  • 3-(ethyliminomethyleneamino)propyl-dimethyl-amine; hydron; chloride
  • 3-(ethyliminomethylideneamino)-N,N-dimethyl-propan-1-amine; hydron; chloride
  • 3-(ethyliminomethylideneamino)-N,N-dimethyl-propan-1-amine hydrochloride
  • [3-(Dimethylamino)propyl]ethyl carbodiimide hydrochloride
  • 1-Ethyl-3-(3′-dimethylaminopropyl)carbodiimide, HCl
  • EDAC, Hydrochloride
  • 1-Ethyl-3-(3'-dimethylaminopropyl)carbodiimide hydrochloride
  • 1-Ethyl-3-[(3-(dimethylamino)propyl]carbodiimide hydrochloride
  • 1-Ethyl-3-[3'-(dimethylamino)propyl]carbodiimide hydrochloride
  • 1-Ethyl-3-[3-(dimethylamino)propyl]carbodiimide monohydrochloride
  • Carbodiimide, [3-(dimethylamino)propyl]ethyl-, hydrochloride
  • Carbodiimide, [3-(dimethylamino)propyl]ethyl-, monohydrochloride
  • N-Ethyl-N'-[3-(dimethylamino)propyl]carbodiimide hydrochloride
  • N-[3-(Dimethylamino)propyl]-N'-ethylcarbodiimide hydrochloride
  • WLN: 2NCN3N1&1 &GH
InChIKey FPQQSJJWHUJYPU-UHFFFAOYSA-N
InChI InChI=1S/C8H17N3.ClH/c1-4-9-8-10-6-5-7-11(2)3;/h4-7H2,1-3H3;1H
SMILES CCN=C=NCCCN(C)C.Cl
Cited Uses

Details

1. Zhao Q et al, "A reusable localized surface plasmon resonance biosensor for quantitative detection of serum squamous cell carcinoma antigen in cervical cancer patients based on silver nanoparticles array", International Journal of Nanomedicine, 9() pp.1097-1104 ().
2. Bruss H et al, "Synthesis of the B-seco limonoid core scaffold", Beilstein Journal of Organic Chemistry, 10() pp.194-208 ().
3. Sanphui P et al, "Efficacy of Cyclin Dependent Kinase 4 Inhibitors as Potent Neuroprotective Agents against Insults Relevant to Alzheimer's Disease", PLoS ONE, 8(11) pp.e78842 ().
4. Gao H et al, "The impact of PEGylation patterns on the in vivo biodistribution of mixed shell micelles", International Journal of Nanomedicine, 8() pp.4229-4246 (2013).
5. Cheng M et al, "Glycyrrhetinic acid-modified chitosan nanoparticles enhanced the effect of 5-fluorouracil in murine liver cancer model via regulatory T-cells", Drug Design, Development and Therapy, 7() pp.1287-1299 ().
6. Hu XJ et al, "Synthesis and characterization of low-toxicity N-caprinoyl-N-trimethyl chitosan as self-assembled micelles carriers for osthole", International Journal of Nanomedicine, 8() pp.3543-3558 (2013).
7. Coste A et al, "Concise Total Synthesis of (+)-Bionectins A and C", Chemical science (Royal Society of Chemistry : 2010), 4(8) pp.3191-3197 (2013 Aug).
8. Jung ME et al, "A Bis(phosphine)-Modified Peptide Ligand for Stable and Luminescent Quantum Dots in Aqueous Media", Synthesis, 45(17) pp.2426-2430 (2013 Sep 1).
9. Shang K et al, "Accelerated In Vitro Degradation of Optically Clear Low β-Sheet Silk Films by Enzyme-Mediated Pretreatment", Translational Vision Science & Technology, 2(3) pp.2 ().
10. Gunosewoyo H et al, "Characterization of Maleimide-Based Glycogen Synthase Kinase-3 (GSK-3) Inhibitors as Stimulators of Steroidogenesis", Journal of medicinal chemistry, 56(12) pp.5115-5129 (2013 Jun 27).
11. Yu M et al, "Incorporation of Bulky and Cationic Cyclam-Triazole Moieties into Marimastat Can Generate Potent MMP Inhibitory Activity without Inducing Cytotoxicity", ChemistryOpen, 2(3) pp.99-105 (2013 Jun).
12. Bibian M et al, "Development of highly selective casein kinase 1?/1? (CK1?/?) inhibitors with potent antiproliferative properties", Bioorganic & medicinal chemistry letters, 23(15) pp.4374-4380 (2013 Aug 1).
13. Renwick N et al, "Multicolor microRNA FISH effectively differentiates tumor types", The Journal of Clinical Investigation, 123(6) pp.2694-2702 (2013 Jun 3).
14. Njogu PM et al, "Design, Synthesis, and Antiplasmodial Activity of Hybrid Compounds Based on (2R,3S)-N-Benzoyl-3-phenylisoserine", ACS Medicinal Chemistry Letters, 4(7) pp.637-641 ().
15. Kormos CM et al, "Discovery of N-{4-[(3-Hydroxyphenyl)-3-methylpiperazin-1-yl]methyl-2-methylpropyl}-4-phenoxybenzamide Analogues as Selective Kappa Opioid Receptor Antagonists", Journal of medicinal chemistry, 56(11) pp.4551-4567 (2013 Jun 13).
16. Wencewicz TA et al, "Biscatecholate-Monohydroxamate Mixed Ligand Siderophore-Carbacephalosporin Conjugates are Selective Sideromycin Antibiotics that Target Acinetobacter baumannii", Journal of medicinal chemistry, 56(10) pp.4044-4052 (2013 May 23).
17. Shang K et al, "Accelerated in vitro Degradation of Optically Clear Low β-sheet Silk Films by Enzyme-Mediated Pretreatment", JAMA ophthalmology, 131(5) pp.676 (2013 May).
18. Wang C et al, "Radiosynthesis and Evaluation of [11C]EMPA as a potential PET Tracer for Orexin 2 Receptors", Bioorganic & medicinal chemistry letters, 23(11) pp.3389-3392 (2013 Jun 1).
19. Zhao L et al, "Stem Cell Labeling using Polyethylenimine Conjugated (?-NaYbF4:Tm3+)/CaF2 Upconversion Nanoparticles", Theranostics, 3(4) pp.249-257 ().
20. Lai J et al, "Versatile FRET-Based Mesoporous Silica Nanoparticles for Real-Time Monitoring of Drug Release", ACS nano, 7(3) pp.2741-2750 (2013 Mar 26).
21. Ochoa-Puentes C et al, "Benzanilide-Biphenyl Replacement: A Bioisosteric Approach to Quinoline Carboxamide-Type ABCG2 Modulators", ACS Medicinal Chemistry Letters, 4(4) pp.393-396 ().
22. Dang Z et al, "New Betulinic Acid Derivatives for Bevirimat-Resistant Human Immunodeficiency Virus Type-1", Journal of medicinal chemistry, 56(5) pp.2029-2037 (2013 Mar 14).
23. Bava A et al, "Heparin and Carboxymethylchitosan Metal Nanoparticles: An Evaluation of Their Cytotoxicity", BioMed Research International, 2013() pp.314091 (2013).
24. Wencewicz TA et al, "Trihydroxamate Siderophore-Fluoroquinolone Conjugates are Selective Sideromycin Antibiotics that Target Staphylococcus aureus", Bioconjugate chemistry, 24(3) pp.473-486 (2013 Mar 20).
25. Avital-Shmilovici M et al, "Fully Convergent Chemical Synthesis of Ester Insulin: Determination of the High Resolution X-ray Structure by Racemic Protein Crystallography", Journal of the American Chemical Society, 135(8) pp.3173-3185 (2013 Feb 27).
Reviews
cr